218 related articles for article (PubMed ID: 10652367)
1. Potent inhibition of the master chondrogenic factor Sox9 gene by interleukin-1 and tumor necrosis factor-alpha.
Murakami S; Lefebvre V; de Crombrugghe B
J Biol Chem; 2000 Feb; 275(5):3687-92. PubMed ID: 10652367
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Sox9 activity by crosstalk with nuclear factor-kappaB and retinoic acid receptors.
Rockel JS; Kudirka JC; Guzi AJ; Bernier SM
Arthritis Res Ther; 2008; 10(1):R3. PubMed ID: 18182117
[TBL] [Abstract][Full Text] [Related]
3. Modulation of TGF-beta signaling by proinflammatory cytokines in articular chondrocytes.
Roman-Blas JA; Stokes DG; Jimenez SA
Osteoarthritis Cartilage; 2007 Dec; 15(12):1367-77. PubMed ID: 17604656
[TBL] [Abstract][Full Text] [Related]
4. Chondrocyte phenotype and cell survival are regulated by culture conditions and by specific cytokines through the expression of Sox-9 transcription factor.
Kolettas E; Muir HI; Barrett JC; Hardingham TE
Rheumatology (Oxford); 2001 Oct; 40(10):1146-56. PubMed ID: 11600745
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor alpha and epidermal growth factor act additively to inhibit matrix gene expression by chondrocyte.
Klooster AR; Bernier SM
Arthritis Res Ther; 2005; 7(1):R127-38. PubMed ID: 15642133
[TBL] [Abstract][Full Text] [Related]
6. SOX9 expression does not correlate with type II collagen expression in adult articular chondrocytes.
Aigner T; Gebhard PM; Schmid E; Bau B; Harley V; Pöschl E
Matrix Biol; 2003 Jun; 22(4):363-72. PubMed ID: 12935820
[TBL] [Abstract][Full Text] [Related]
7. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene.
Lefebvre V; Huang W; Harley VR; Goodfellow PN; de Crombrugghe B
Mol Cell Biol; 1997 Apr; 17(4):2336-46. PubMed ID: 9121483
[TBL] [Abstract][Full Text] [Related]
8. JAK/STAT but not ERK1/ERK2 pathway mediates interleukin (IL)-6/soluble IL-6R down-regulation of Type II collagen, aggrecan core, and link protein transcription in articular chondrocytes. Association with a down-regulation of SOX9 expression.
Legendre F; Dudhia J; Pujol JP; Bogdanowicz P
J Biol Chem; 2003 Jan; 278(5):2903-12. PubMed ID: 12419823
[TBL] [Abstract][Full Text] [Related]
9. BMP-2 and BMP-9 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes the inhibitory effect of IL-1.
Majumdar MK; Wang E; Morris EA
J Cell Physiol; 2001 Dec; 189(3):275-84. PubMed ID: 11748585
[TBL] [Abstract][Full Text] [Related]
10. Chondrocyte-specific enhancer elements in the Col11a2 gene resemble the Col2a1 tissue-specific enhancer.
Bridgewater LC; Lefebvre V; de Crombrugghe B
J Biol Chem; 1998 Jun; 273(24):14998-5006. PubMed ID: 9614107
[TBL] [Abstract][Full Text] [Related]
11. Sox9 expression during chondrogenesis in micromass cultures of embryonic limb mesenchyme.
Kulyk WM; Franklin JL; Hoffman LM
Exp Cell Res; 2000 Mar; 255(2):327-32. PubMed ID: 10694448
[TBL] [Abstract][Full Text] [Related]
12. Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis.
Zhao Q; Eberspaecher H; Lefebvre V; De Crombrugghe B
Dev Dyn; 1997 Aug; 209(4):377-86. PubMed ID: 9264261
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional coactivator PGC-1alpha regulates chondrogenesis via association with Sox9.
Kawakami Y; Tsuda M; Takahashi S; Taniguchi N; Esteban CR; Zemmyo M; Furumatsu T; Lotz M; Izpisúa Belmonte JC; Asahara H
Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2414-9. PubMed ID: 15699338
[TBL] [Abstract][Full Text] [Related]
14. Bcl-2 positively regulates Sox9-dependent chondrocyte gene expression by suppressing the MEK-ERK1/2 signaling pathway.
Yagi R; McBurney D; Horton WE
J Biol Chem; 2005 Aug; 280(34):30517-25. PubMed ID: 15975921
[TBL] [Abstract][Full Text] [Related]
15. Coordinate down-regulation of cartilage matrix gene expression in Bcl-2 deficient chondrocytes is associated with decreased SOX9 expression and decreased mRNA stability.
Kinkel MD; Horton WE
J Cell Biochem; 2003 Apr; 88(5):941-53. PubMed ID: 12616533
[TBL] [Abstract][Full Text] [Related]
16. Three high mobility group-like sequences within a 48-base pair enhancer of the Col2a1 gene are required for cartilage-specific expression in vivo.
Zhou G; Lefebvre V; Zhang Z; Eberspaecher H; de Crombrugghe B
J Biol Chem; 1998 Jun; 273(24):14989-97. PubMed ID: 9614106
[TBL] [Abstract][Full Text] [Related]
17. Retroviral transduction with SOX9 enhances re-expression of the chondrocyte phenotype in passaged osteoarthritic human articular chondrocytes.
Tew SR; Li Y; Pothacharoen P; Tweats LM; Hawkins RE; Hardingham TE
Osteoarthritis Cartilage; 2005 Jan; 13(1):80-9. PubMed ID: 15639641
[TBL] [Abstract][Full Text] [Related]
18. SFMBT2 positively regulates SOX9 and chondrocyte proliferation.
Hussain S; Sun M; Guo Y; Mushtaq N; Zhao Y; Yuan Y; Hussain N; Osoro E; Suleiman A; Sadiq M; Zhang F; Han Y; Sun J; Lu S
Int J Mol Med; 2018 Dec; 42(6):3503-3512. PubMed ID: 30272322
[TBL] [Abstract][Full Text] [Related]
19. Sox9 is required for cartilage formation.
Bi W; Deng JM; Zhang Z; Behringer RR; de Crombrugghe B
Nat Genet; 1999 May; 22(1):85-9. PubMed ID: 10319868
[TBL] [Abstract][Full Text] [Related]
20. Sox9-dependent transcriptional regulation of the proprotein convertase furin.
Guimont P; Grondin F; Dubois CM
Am J Physiol Cell Physiol; 2007 Jul; 293(1):C172-83. PubMed ID: 17360815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
